First Pacific Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.27K Sell
108
-3
-3% -$200 ﹤0.01% 443
2026
Q1
$6.97K Buy
111
+3
+3% +$209 ﹤0.01% 418
2025
Q4
$7.17K Sell
108
-3
-3% -$194 ﹤0.01% 372
2025
Q3
$7.47K Buy
111
+3
+3% +$237 ﹤0.01% 346
2025
Q2
$9.43K Hold
108
﹤0.01% 329
2025
Q1
$7.38K Hold
108
﹤0.01% 324
2024
Q4
$8.4K Hold
108
﹤0.01% 276
2024
Q3
$7.24K Hold
108
﹤0.01% 283
2024
Q2
$12.2K Hold
108
﹤0.01% 243
2024
Q1
$15K Hold
108
﹤0.01% 242
2023
Q4
$13.4K Sell
108
-29
-21% -$2.96K ﹤0.01% 236
2023
Q3
$12.8K Buy
137
+108
+372% +$12.2K 0.01% 213
2023
Q2
$3.73K Buy
+29
New +$3.51K ﹤0.01% 209

Other funds holding DXCM

First Pacific Financial's DXCM Position: Q2 2026 in Review

First Pacific Financial reduced its DexCom (DXCM) stake by 2.7% in Q2 2026, selling an estimated $200 and leaving 108 shares worth $7.27K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

First Pacific Financial first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $15K in Q1 2024. 274 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • First Pacific Financial held 108 shares of DexCom worth $7.27K as of Q2 2026.
  • First Pacific Financial sold 3 DexCom shares in Q2 2026, an estimated $200.
  • DexCom made up ﹤0.01% of First Pacific Financial's portfolio in Q2 2026, its #443 holding.
  • First Pacific Financial first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • First Pacific Financial's DexCom position peaked at $15K in Q1 2024.
  • 274 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.